SEC Form 4 · accession 0000950138-18-000446
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dagmar Rosa-Bjorkeson
Officer — Chief Strat & Corp Dev Officer
Period of report
Jun 1, 2018
Accepted (ET)
Jun 5, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 1, 2018 | F | 247 | $17.05 | D | 15,853 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.